Overview

Update
Status
Acquired by on March 30, 2015
IPO / Stock
Went Public on Jul 25, 2013 / NASDAQ:ICEL
Headquarters:
Madison, WI
Description:
Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.
Founders:
, , , , ,
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.cellulardynamics.com
Social:

Company Details

Update
Founded:
2004
Contact:
6083105101
Employees:
51 - 100 | 14 in Crunchbase

Cellular Dynamics International, Inc. develops stem cell technologies for drug development and personalized medicine applications. It offers drug screening and toxicity testing products based on induced pluripotent stem (iPS) cell technology. The company also provides cardiac toxicity drug testing services, including GLP and non-GLP hERG electrophysiological assays, as well as action potential and cytotoxicity screens using cardiomycytes. In addition, it offers pluripotent stem cell derived products, including cardiomyocytes, hematopoietic cells, neural cells, and hepatocytes. Cellular Dynamics International, Inc. was formerly known as iPS Cells Inc. and changed its name to Cellular Dynamics International, Inc. in July 2008. The company was founded in 2004 and is based in Madison, Wisconsin.

Funding Rounds (4) - $111.64M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2013$20M / Debt Financing0
Nov, 2012$21.04M / Private Equity0
Apr, 2011$30M / Series B1
Apr, 2010$40.6M / Series B3

Current Team (14)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Headquarters

    525 Science Drive

    Madison, WI 53711

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos